Erin Murphy

Active 1993–2025

29
Papers
21,206
Citations
23
h-index
23
i10-index

Citations

Citations per year for Erin Murphy1926: 1 citations1945: 1 citations1992: 1 citations1994: 7 citations1995: 4 citations1996: 10 citations1997: 15 citations1998: 66 citations1999: 66 citations2000: 63 citations2001: 84 citations2002: 117 citations2003: 126 citations2004: 138 citations2005: 126 citations2006: 182 citations2007: 247 citations2008: 293 citations2009: 277 citations2010: 237 citations2011: 233 citations2012: 220 citations2013: 177 citations2014: 203 citations2015: 175 citations2016: 169 citations2017: 186 citations2018: 261 citations2019: 809 citations2020: 961 citations2021: 1,015 citations2022: 787 citations2023: 577 citations2024: 725 citations2025: 310 citations2026: 12 citations1927–1944: no citations, so these years are not shown1946–1991: no citations, so these years are not shown1993: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,804 citing papers, 28.6% of this breakdownChina: 1,732 citing papers, 13% of this breakdownUnited Kingdom: 822 citing papers, 6.2% of this breakdownGermany: 737 citing papers, 5.5% of this breakdownJapan: 660 citing papers, 5% of this breakdownItaly: 556 citing papers, 4.2% of this breakdownFrance: 535 citing papers, 4% of this breakdownCanada: 390 citing papers, 2.9% of this breakdownSpain: 348 citing papers, 2.6% of this breakdownAustralia: 335 citing papers, 2.5% of this breakdownSwitzerland: 330 citing papers, 2.5% of this breakdownNetherlands: 327 citing papers, 2.4% of this breakdown
0%28.6%Other 20.6%

Fields

  • Medicine53.6%
  • Immunology and Microbiology27.6%
  • Biochemistry, Genetics and Molecular Biology16%
  • Neuroscience1%
  • Engineering0.5%
  • Agricultural and Biological Sciences0.2%
  • Other1.1%

Topics

  • Cancer Immunotherapy and Biomarkers9.4%
  • Immunotherapy and Immune Responses6.1%
  • Immune Cell Function and Interaction5.3%
  • IL-33, ST2, and ILC Pathways5%
  • Chemokine receptors and signaling3.7%
  • Immune cells in cancer2.5%
  • Other68%

Coauthors

All papers

Open in search
  1. IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade

    Authors: , , , , , , , , , , , , , , - Journal of Clinical Investigation 2017 cited by 3,872

  2. Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Science 2018 cited by 2,380

  3. IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated Cytokines

    Authors: , , , , , , , , , , , , - Immunity 2005 cited by 3,699

  4. Involvement of chemokine receptors in breast cancer metastasis

    Authors: , , , , , , , , , , , , , - Nature 2001 cited by 5,337

  5. PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancer

    Authors: , , , , , , , , , , , , - Clinical Cancer Research 2017 cited by 604

  6. IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6

    Authors: , , , , , , , , , , , , , , - Journal of Clinical Investigation 2006 cited by 1,527

  7. IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2–dependent mechanisms with implications for psoriasis pathogenesis

    Authors: , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2006 cited by 673

  8. IL-10 Elicits IFNγ-Dependent Tumor Immune Surveillance

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martin Oft - Cancer Cell 2011 cited by 414

  9. Pivotal Study Evaluating the Safety and Effectiveness of the Abre Venous Self-Expanding Stent System in Patients With Symptomatic Iliofemoral Venous Outflow Obstruction

    Authors: , , , , , , - Circulation Cardiovascular Interventions 2022 cited by 82

  10. T‐cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death‐ligand 1 expression in patients with soft tissue sarcomas

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Cancer 2017 cited by 271

  11. Neoadjuvant Therapy Induces a Potent Immune Response to Sarcoma, Dominated by Myeloid and B Cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2022 cited by 46

  12. IGIF Does Not Drive Th1 Development but Synergizes with IL-12 for Interferon-γ Production and Activates IRAK and NFκB

    Authors: , , , , , , , , , , - Immunity 1997 cited by 723

  13. The LXR agonist TO901317 selectively lowers hippocampal Aβ42 and improves memory in the Tg2576 mouse model of Alzheimer's disease

    Authors: , , , , , , , , , , , , , , , , , , , , , - Molecular and Cellular Neuroscience 2007 cited by 248

  14. Building a translational cancer dependency map for The Cancer Genome Atlas

    Authors: , , , , , , , , , , , , , , , , , - Nature Cancer 2024 cited by 28

  15. Reversibility of T helper 1 and 2 populations is lost after long-term stimulation.

    Authors: , , , , , , , - The Journal of Experimental Medicine 1996 cited by 438

  16. Expression patterns of IL-10 ligand and receptor gene families provide leads for biological characterization

    Authors: , , , - International Immunopharmacology 2004 cited by 140

  17. Myostatin inhibition slows muscle atrophy in rodent models of amyotrophic lateral sclerosis

    Authors: , , , , , , , , , , , , , , , , , , - Neurobiology of Disease 2006 cited by 93

  18. Small Molecule and Pooled CRISPR Screens Investigating IL17 Signaling Identify BRD2 as a Novel Contributor to Keratinocyte Inflammatory Responses

    Authors: , , , , , , , , , , , , , , , , , , , , - ACS Chemical Biology 2019 cited by 23

  19. Video Prototyping for Interaction Design Across Multiple Displays in the Commercial Flight Deck

    Authors: , , , , , , , - Conference on Designing Interactive Systems 2017 cited by 3

  20. IL-33 Induces IL-13–Dependent Cutaneous Fibrosis

    Authors: , , , , , , , , , - The Journal of Immunology 2009 cited by 216

  21. Association of response to programmed death receptor 1 (PD-1) blockade with pembrolizumab (MK-3475) with an interferon-inflammatory immune gene signature.

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2015 cited by 199

  22. The Racial Composition of Forensic DNA Databases

    Authors: , - 2019 cited by 38

  23. Ensemble Labeling Towards Scientific Information Extraction (ELSIE)

    Authors: , , , , - Lecture notes in computer science, ICCS (1) 2021 cited by 6

  24. Detection of in vivo expression of interleukin-10 using a semi-quantitative polymerase chain reaction method in Schistosoma mansoni infected mice

    Authors: , , , - Journal of Immunological Methods 1993 cited by 97